Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Boehringer Ingelheim
Farmers Insurance
Mallinckrodt
US Department of Justice
McKinsey
Colorcon
Julphar

Generated: April 22, 2018

DrugPatentWatch Database Preview

ATROPINE AND DEMEROL Drug Profile

« Back to Dashboard

Which patents cover Atropine And Demerol, and what generic alternatives are available?

Atropine And Demerol is a drug marketed by Abbvie and is included in three NDAs.

The generic ingredient in ATROPINE AND DEMEROL is atropine sulfate; meperidine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.
Summary for ATROPINE AND DEMEROL
Drug patent expirations by year for ATROPINE AND DEMEROL

US Patents and Regulatory Information for ATROPINE AND DEMEROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie ATROPINE AND DEMEROL atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 087853-001 Nov 26, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie ATROPINE AND DEMEROL atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 087847-001 Nov 26, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie ATROPINE AND DEMEROL atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 087848-001 Nov 26, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Teva
Colorcon
Fish and Richardson
Queensland Health
Medtronic
Dow
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.